Crispr Therapeutics AG (CRSPN) Q4 2019 Earnings Report
1 Followers
MX:CRSPN Q4 2019 EPS Results
- Actual EPS
- MXN 9.61
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -MXN 17.33
MX:CRSPN Q4 2019 Revenue Results
- Actual Revenue
- MXN 1.45B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +66870.43%
Earnings Announcement Details
- Quarter
- Q4 2019
- Date
- 02/12/2020
- Time
- After Close
- Conference Call
- Wednesday, February 12, 2020
MX:CRSPN Upcoming Earnings
Crispr Therapeutics AG's next earnings date is estimated for February 16, 2027, based on past reporting schedules.
Q4 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:CRSPN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 16, 2027 | 2026 (Q4) | -22.12- | -25.81 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -19.53-21.66 | -22.04 | 1.71% (+0.38) | |
| Aug 03, 2026 | 2026 (Q2) | -22.51-17.71 | -45.21 | 60.83% (+27.50) | |
| May 04, 2026 | 2026 (Q1) | -22.94-24.11 | -29.76 | 18.99% (+5.65) | |
| Feb 12, 2026 | 2025 (Q4) | -21.91-25.81 | -8.29 | -211.36% (-17.52) | |
| Nov 10, 2025 | 2025 (Q3) | -23.83-22.04 | -19.03 | -15.84% (-3.01) | |
| Aug 04, 2025 | 2025 (Q2) | -26.41-45.21 | -28.07 | -61.07% (-17.14) | |
| May 06, 2025 | 2025 (Q1) | -23.43-29.76 | -26.94 | -10.49% (-2.83) | |
| Feb 11, 2025 | 2024 (Q4) | -22.62-8.29 | 20.72 | -140.00% (-29.01) | |
| Nov 05, 2024 | 2024 (Q3) | -26.52-19.03 | -26.56 | 28.37% (+7.53) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
